Apologies to my English speaking Readers - this entire blog, and videos presented, are in German, the subject has to do with German (and also Austrian) Politics.
Entschuldigung an meine englischsprachigen Leser - dieser gesamte Blog und die präsentierten Videos sind auf Deutsch, das Thema hat mit deutscher (und auch österreichischer) Politik zu tun.
Ich präsentiere hier eine Zusammenfassung von Themen auf die ich letztlich aufmerksam wurde. Ich fand z.B. sehr verwunderlich und schlichtweg unfassbar die Verschwendung von Steuergeldern, besonders wenn wir daran denken dass dies ja nicht das erste Mal passierte - man denke da an die Schweinegrippe 2009 zurück. Das folgende video deckt auf:
Maskendebakel: Wer zahlt die teure Beschaffung des Bundes?
Im März 2020 beschloss das Bundesgesundheitsministerium, selbst Schutzausrüstung zu beschaffen: mit mehr als 700 Verträgen über insgesamt rund 6,4 Milliarden Euro. Jetzt sitzen Lieferanten auf der bestellten Ware und warten auf ihr Geld.
Eines der Kommentare:
Erinnert doch irgendwie an 2009, dort hat der Bund auch jede Menge Steuergelder im Namen der Pandemie verbrannt..... Profiteure der Angst (Arte-Doku 2009) Fragt man sich nur was die Qualitätsjournalisten daraus lernen..........
Im direkten Zusammenhang damit - wir reden jetzt über März 2020 - erinnere ich mich dass es ein Ausfuhrverbot für Atemmasken gab. Auf einer Google Suche wurde ich fündig:
Beim Corona-Schutz endet Europas Solidarität. Der Krisenstab der Bundesregierung reagiert nun auf die gestrige Beschlagnahmung von Atemmasken in Frankreich. Sie nimmt die Beschaffung jetzt selbst in die Hand.
Eine weitere Überschrift:
Atemschutzmasken und Desinfektionsmittel ausverkauft
Die einschneidendste Maßnahme ist aber der Ausfuhrstopp. Aufgrund der Krisenlage durch die Epidemie habe sich der globale Bedarf an medizinischer Schutzausrüstung bedeutend erhöht, so die Bundesregierung. Das Exportverbot diene dem Schutz von Leben und Gesundheit der Menschen und stehe damit im Einklang mit den Regeln der Europäischen Union, unterstreicht Wirtschaftsstaatssekretär Ulrich Nussbaum, der die formelle Anweisung unterschrieben hat.
„Die Deckung des Bedarfs mit den genannten Gütern ist für die Aufrechterhaltung eines funktionierenden Gesundheitssystems in der Bundesrepublik Deutschland unerlässlich“, heißt es zur Begründung.
Ich empfehle den gesamten Artikel hier zu lesen.
Jedoch geht es weiter, und über diese Masken diskutieren wir noch immer, hier der Anfang, ein Artikel vom Jänner 2020:
Es gibt dort noch so einige weiterführende Links, doch möchte ich in die Gegenwart zurückkehren - ein Video auf das ich erst gestern aufmerksam wurde, stammt von September 2020:
Dr Daniele Ganser Corona und die Medien - Düsseldorf 11 September 2020
Während der Corona-Krise hat der Schweizer Historiker und Friedensforscher Dr. Daniele Ganser in Düsseldorf am 11. September 2020 erstmals öffentlich einige Bemerkungen zum Thema Corona gemacht.
Schlussendlich lassen wir einen renommierten Virologen zu Wort kommen:
Virologe Hendrik Streeck zur neuesten Entwicklung der Corona-Lage am 23.10.20
Im Interview äußert sich Virologe Hendrik Streeck zu den aktuellen Zahlen der Infizierten und warnte im Gespräch mit Moderator Michael Krons davor, nur die bloßen Zahlen für die Entwicklung der Corona-Pandemie zu berücksichtigen.
Über das Thema Berchtesgaden teile ich hier eine satyrische Ansicht von Claudio Michele Mancini:
Zitat von CCM
...ich wills mal so sagen:
In der eigenen Nase verliert der pädagogisch erhobene Zeigefinger signifikant an Bedeutung. enen Nase verliert der pädagogisch erhobene Zeigefinger signifikant an Bedeutung
Apropos "Erhobener Zeigefinger" - wer Lust und Laune hat, seht euch die Österreichische Pressekonferenz vom 23.10. bei unserem Gesundheitsminister Rudi Anschober auf Facebook an:
Rudi Anschober was live.
Pressekonferenz zur Ampelschaltung
Some time ago I joined a new Print-On-Demand platform, headquartered in Montreal, Canada. There are a multitude of items I can put my designs on, and to see an overview of it, just check my AOW STORE. But in this blog, I like to highlight my collection of Facemask that have become mandatory in many places around the globe. So why not make it a fashion accessory that is unique and not mass-produced!
There are basically two types of masks, which I want to introduce to you:
a very affordable yet elegant style - select from the images below (opens in new tab) or click the title above to take you the store category if you wish to make multiple purchases.
Note: there are additional designs also available - more may be added
Add some flair to our new normal with custom printed double knit face coverings! These super vibrant face coverings are made of a light weight, double knit polyester, making them easy to breathe, move, and even exercise in. Precision cut edges and plenty of stretch provide comfort for all day use. Whether you’re going to the grocery store, the gym, the office, or wherever else you choose to social distance, these double knit face coverings will keep you safe, comfortable and stylish.
How to measure:
Measure from the beginning of one ear, over the tip of your nose, to the start of your other ear.
Adult Large 29-30cm
Adult Medium 27-28cm
Adult Small 26-27cm
Youth Large 24-25cm
Youth Small 22-23cm
With the world changing all around us, we’ve all had to come to terms with our “new normal”. Wearing a mask all day can be pretty uncomfortable and can inhibit some of our daily routines. I get that, which is why my double knit face coverings are designed with functionality in mind. Say goodbye to heavy breathing, face sweats and mask induced pimples! These lightweight, breathable face coverings are made of a super stretchy, double knit poly, and finished with precision cut edges, so they’re comfortable enough to wear all day. Their gorgeously vibrant prints will never fade, so you can wash them everyday without worry. Not only are they comfortable and easy to wear, they’ll also do what all good face coverings should do, which is keep you safe during these unknown times. Add some flair to your new normal with these double knit face coverings!
the deluxe premium you can take to the opera - select from the images below (opens in new tab) or click the title above to take you the store category if you wish to make multiple purchases.
Note: there are additional designs also available - more may be added
Keep up with our changing world with 100% cotton custom printed face coverings! Complete with a stainless steel nose piece, filter pocket and soft fabric elastics, these 200 thread count cotton sateen face coverings are here to give you a little more peace of mind. Printed with permanent reactive inks, you can feel confident washing them over and over without fear of fading. Stay safe and stylish with custom printed cut and sew face coverings.
How to measure:
Measure from the beginning of one ear, over the tip of your nose, to the start of your other ear.
Adult X-Large 30.5 cm
Adult Large 29 cm
Adult Medium 27.5 cm
Adult Small 26 cm
Youth Large 25 cm
Youth Medium 23.5 cm
Youth Small 22 cm
We’re all trying to go the extra mile right now to stay safe and sanitary in the face of the global COVID-19 pandemic. Part of that is covering our faces in public. My 200 thread count cotton sateen face coverings are silky soft against your skin and printed with permanent reactive inks so they won’t fade even after endless washes. They feature a stainless steel nose piece to ensure a tight fit, and soft fabric elastic that can be adjusted to fit your head shape. They have an internal filter pocket which acts as the double layer of fabric while also allowing you to insert an additional filter suited to your needs. While we don’t have a choice to change our lifestyles to suit the world, we do get to choose the artwork that we wear! Cover up with custom printed face coverings and stay safe and stylish!
After a lengthy absence, I re-publish this interesting article which sort of mirrors
what I posted about in April:
FOREST BATHING - WALD GEGEN CORONA-VIREN
A radical nature-based agenda would help society overcome the psychological effects of coronavirusMatthew Adams, University of Brighton
More of us than ever are stuck indoors, whether we are working at home, self-isolating, or socially distancing from other households. Long periods of isolation are already impacting many people’s mental health and will continue to do so.
This reinforces the surge of research exploring the psychological benefits of connecting to nature that has developed in recent years. The idea is also growing that encouraging time in and engagement with nature has enormous potential in terms of mental health and wellbeing.
There are more and more programmes explicitly aimed at helping people with experiences of distress by providing structured contact with nature. These are variously referred to as nature-based interventions, ecotherapy or green care. A growing evidence base suggests they are effective in alleviating distress and fostering recovery and resilience – for people but also, at least potentially, for nature too.
I think programmes like this need to be rolled out en masse, with a few vital provisos.
My work often involves evaluating nature-based interventions from a psychological perspective. I have repeatedly witnessed the benefits of time spent in nature for those involved.
One organisation I work with, called Grow, takes small groups of six to eight people – often strangers at first – into nature. Participants all suffer, or have suffered, from debilitating forms of psychological distress and are recruited on that basis. Like many such services, Grow operates with funding from sources like the National Lottery, larger charities and local council grants to run a number of programmes a year.
Clients are not yet referred through or commissioned by the health service. Your doctor might be more likely today to suggest you get outside more in a move towards green prescriptions. But institutionalised health provision is still catching up with the evidence of the benefits of structured, supported and sustained contact with nature.
At Grow, trained professionals run a series of activities to help participants connect to nature on daily trips, once a week, for eight weeks. Activities include mindfulness, silent walks, foraging, sharing food, identifying flora and fauna, building fires, arts and crafts using natural objects, and reflective diaries, alongside more traditional active conservation activity like planting, clearing and coppicing.
Colleagues and I have collected surveys, diaries and interview data about the project over a number of years. Our findings reveal how transformative the experience has been for participants. (I was so impressed I later became a trustee of the charitable organisation involved.) We found plenty of evidence of the psychological benefits of nature connection, but also, vitally, something else – a deepening of social connectedness.
For people struggling emotionally, socially or psychologically, just being in nature seems to rekindle their ability to relate to and engage with others. Feeling present and “held” by the natural environment can nurture new and positive forms of social contact, which in turn enhances experiences of nature.
So for me, while there are always important caveats (such as the need for on-hand trained professional support), the benefits of a range of nature-based projects are unequivocal. They can be used as therapeutic interventions for people struggling to cope. They also work preventatively, by helping to maintain a sense of wellbeing, happiness, awe and belonging.
A human right
The impact of coronavirus-induced isolation on mental health is already mirrored in rising psychiatric diagnoses. And so the need for these kinds of interventions has never been greater. It is not enough to just encourage people outdoors. For many, access to nature is practically difficult. For others, it is an alien concept.
There are projects like Grow across the world and they are chronically underfunded. We need more of them. We need our governments to be funding projects like this as a matter of urgency, rolling them out on a national scale. Doctors, nurses and other primary care professionals should be able to refer people to local green care services as part of a wider shift towards “social prescribing”.
This is not only a psychological issue. Access to nature is not equal. The richest 20% of areas in England offer access to five times the amount of green space as the most deprived 10%.
If nature is so fundamental to our wellbeing, it should be understood as a right rather than a luxury. This is why diverse organisations such as walkers’ rights group the Ramblers and the mental health charity MIND are increasingly calling for legally binding targets that guarantee people’s access to nature. This should be part of a radical shake up of health and care policy.
We also cannot ignore the fact that nature is in retreat, decimated as ecological devastation is wrought across the globe. In this context, contact with nature might seem futile, contradictory even. There is arguably something perverse about asking nature to make us well at the same time as we are destroying it.
But the movement is evolving rapidly. One of the most promising developments I’ve seen is the growth of “reciprocal restoration” projects – interventions explicitly designed to combine restoring people with restoring natural environments.
The potential for more collective forms of green care, such as the mass mobilisation of volunteers, is well worth exploring. Evidence also suggests that the more access to nature we have, the more we come to care for and want to defend the natural world.
There are already signs that we are at last more willing to face up to the realities of ecological crisis – if the shift in nature documentaries, the rise of Extinction Rebellion and the growing youth climate movement are anything to go by.
So perhaps it’s possible that an ambitious push for nature-based interventions might further encourage a groundswell of action that is truly restorative – of both humans and nature.
MORE NEWS TO CONSIDER:
Coronavirus: WHO backflips on virus stance by condemning lockdowns
Lockdowns have been used to control the coronavirus around the world.
Now a WHO official has questioned the success of them.
The World Health Organisation has backflipped on its original COVID-19 stance after calling for world leaders to stop locking down their countries and economies.
Dr. David Nabarro from the WHO appealed to world leaders yesterday, telling them to stop “using lockdowns as your primary control method” of the coronavirus.
He also claimed that the only thing lockdowns achieved was poverty – with no mention of the potential lives saved.
“Lockdowns just have one consequence that you must never ever belittle, and that is making poor people an awful lot poorer,” he said. ...........................READ MORE
Ein deutschsprachiger Bericht von St.Corona
Apologies to my English readers - most material presented is in German
Auch Monate nach dem Lockdown hat sich eines nicht geändert: Wer eine andere Meinung hat und die Maßnahmen kritisiert, wird totgeschwiegen. Prof. Dr. Sucharit Bhakdi gilt als renommierter Wissenschaftler und Kritiker der Behörden im Umgang mit dem neuartigen Virus. Mit seinem Buch „Corona Fehlalarm?“ hat er einen Bestseller geschrieben, der besonders von den klassischen Medien, ebenso wie seine Meinung, bis heute ignoriert wird. In einer Zeit, die von dem fragwürdigen Wettstreit um einen Impfstoff dominiert wird, zieht der Wissenschaftler eine Zwischenbilanz. Vier Monate nach ihrem ersten Interview: Ferdinand Wegscheider im Gespräch mit Prof.Dr. Sucharit Bhakdi.
Prof.Dr. Sucharit Bhakdi spricht im obigen Interview unter Anderem auch über Impfstoffe, besonders über den "Oxford" Impfstoff. Um was es hier genau geht erklärt der Biologe Clemens Arvay in seinem neuesten Video.
Biologe Clemens Arvay fordert das Aus des „Oxford-Impfstoffs“ und belegt die erheblichen Gefahren der laufenden Verkürzungen bei Impfstoff-Zulassungsverfahren gegen COVID-19, auf die er bereits im März 2020 hingewiesen hat. (Video-Coverfoto: Tatevosian Yana, Quelle: Shutterstock)
 Clemens Arvays Artikel in der Schweizerischen Ärztezeitung
 In Phase III des „Oxford-Impfstoffs“ trat eine schwere Komplikation auf (transverse Myelits)
 Frühere Videos von Clemens Arvay:
(a) Bill Gates und Covid-19: RNA-Impfstoffe als globale Bedrohung
(b) Genetische Impfstoffe gegen COVID-19: Hoffnung oder Risiko?
(c) Gefahr Corona-Impfstoff: Verheimlichte Nebenwirkungen bei Favoriten
 Die Antikörper waren bei Primaten beim "Oxford-Impfstoff" nicht ausreichend funktionsfähig:
(a) Doubts over Oxford vaccine as it fails to stop coronavirus in animal trials
(b) ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
 Genetiker William Haseltine über mangelnde Wirksamkeit des „Oxford-Impfstoffs“
 Bill Gates stellt im April 2020 die Teleskopierung der Zulassungsverfahren vor
 Die Gates-Stiftung ist Investor des Jenner-Institutes in Oxford, wo das Unternehmen Vaccitech gegründet wurde, welches das Patent auf die „Oxford“-Impfstoff Plattform besitzt. Außerdem tritt die Gates-Stiftung als Investor der Oxford Vaccine Group auf, die an der Entwicklung des Impfstoffs beteiligt ist: (a) Funders & Partners (b) Oxford Vaccine Group
 Vorläufige Auswertung der teleskopierten klinisches Phase I-II durch die überwiegend mit Interessenkonflikten behafteten Studienautoren des "Oxford-Impfstoffs" zeigt signifikante Häufung von Nebenwirkungen: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
 Deutschland hat 80 Millionen des "Oxford-Impfstoffs" gekauft
 Österreich hat 8 Millionen des "Oxford-Impfstoffs" gekauft
 EU-Länder (Großbritannien nicht mitgerechnet) haben 400 Millionen Dosen des "Oxford-Vakzins" eingekauft
 Genetiker William Haseltine warnt vor den Gefahren der teleskopierten Zulassungsverfahren
 Lobbyverband der pharmazeutischen Industrie, Vaccines Europe, räumt erhöhtes Risiko durch verkürzte Zulassungsverfahren ein und fordert daher Haftungsübernahme durch die Staaten:
Covid-19 vaccine makers lobby EU for legal protection
 vorläufige klinische Auswertung zweier mRNA-Impfstoffe, die neben dem Oxford-Impfstoff ebenfalls als Favoriten gehandhabt werden (jedoch von Deutschland und Österreich nicht eingekauft wurden):
(a) An mRNA Vaccine against SARS-CoV-2 — Preliminary Report.
(b) Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
 140 nationale Wissenschaftsakademien kritisieren Verkürzung der Zulassungsverfahren
ein verwandter Artikel über den Oxford-Impfstoff (Englisch)
A related article about the Oxford Vaccine
News that a 'vaccine' might be available in Australia as early as the start of 2021 caused a wave of excitement this week. But don't go booking your overseas travel just yet.
The development of the Oxford University coronavirus vaccine – which offers Australia's best hope of returning to a level of normality – began long before anyone had heard of COVID-19. It started with Disease X.
In 2017, a coalition of governments, universities, research institutions and philanthropic organisations formed the view that a major global pandemic was a matter of when, not if, and they wanted to be prepared.
.......READ MORE IN FINANCIAL TIMES
Cartoon von © David Rowe (link to his twitter account) - image and Financial Times article excerpt published under Fair Use
In diesem Zusammenhang ebenfalls interessant:
Unklarer Trend bei Corona-Fallzahlen
von Dirk Jacobs
Zurzeit ist keine zweite Welle erkennbar - das zeigt auch die Reproduktionsrate r, die beim 7-Tageswert unter 1 liegt, was darauf hindeutet, dass die Fallzahlen leicht sinken.
Video verfügbar bis 27.08.2021
It has been a while since I reported last. The fall numbers are rising everywhere, and some are beginning to panic. The second wave is coming ...... but should we be worried? Two months ago Drosten speculated the virus is mutating and weakening (related article in German). I believe I already passed another article on, but to recap, here it is again: Will mutations soon make COVID-19 less harmful?
Apparently so, if one follows the numbers. More and more people are getting tested, are positive, but have no symptoms or only very mild symptoms. The death rates are flat, hospitalisations are down as well. Below, I republish an article from THE CONVERSATION.
My previous post also talks about not to panic:
CORONAVIRUS REINFECTION – WHAT IT ACTUALLY MEANS, AND WHY YOU SHOULDN’T PANIC
Coronavirus: why aren’t death rates rising with case numbers?Danny Dorling, University of Oxford
It is a conundrum. For much of the past two months, many people have been convinced that mortality associated with COVID-19 would rise as the number of people testing positive with the disease increased. But this has not happened so far. Why? A look at government data from England and Wales can provide some clues.
By late summer 2020, the UK government had finally managed to produce a consistent definition of precisely what constitutes a positive case of coronavirus. It is defined as a person with at least one lab-confirmed positive COVID-19 test result (individuals who tested positive more than once are only counted once, on the date of their first positive test).
The first graph below shows cases by the day on which they were initially reported – represented by the blue line. Cases peaked at 5,451 on April 5, reached a low of 101 on June 10 and very recently have appeared to be rapidly rising again. The most recent rise in cases, to more than 2,600 a day, is particularly unsettling. The red line shows deaths per day, which have been very low for many weeks now and also still falling in number.
It’s important to remember that the number of cases has not been rising because the number of people carrying the disease has been increasing, but instead because more tests are being carried out, and especially in areas where the rate at which people have the disease is found to be higher.
The main reasons why we know that the number of deaths has not been rising is that the actual number of cases in the population has not been rising when measured per million people tested. We know this because the Office for National Statistics (ONS) is running a properly constructed surveillance programme which estimated that by August 25 only one person in every 2,000 in England had the disease, and each week only one person in every 27,000 was catching the disease (this proportion having been essentially stable for several months). The proportion in Wales was even lower at one in 2,200.
The ONS is currently increasing the sample size of its surveillance programme to 400,000 people in England with 150,000 being tested each fortnight in October.
A question of demographics
It is likely that among the steadily rising number of people who have tested positive for the disease since June, an increasing proportion are young and a declining proportion are older, so that having the disease is dramatically less lethal for each person with it. In March and April (before the June minimum was reached) younger adults aged 18-34 had the highest prevalence in antibody testing so we should not be surprised that outside of the most rigorous lockdown, cases are higher among the young.
Your chances of dying with COVID-19 depend primarily on age. Those chances are greatly reduced if you are younger – as the table below shows.
According to this data, by the end of August, someone aged 20-24 had a one in 100,000 chance of having died with a mention of COVID-19 on their death certificate; that risk doubles to one in 50,000 for people aged 30-34 and is more than one in 1,000 for men by age 65 and for women by age 75.
Another way of describing what the table reveals is that a grandmother in her early 90s is 120 times more likely to have died of the disease than her daughter aged 52 who, herself, is 259 times more likely to die than her 14-year-old daughter. Currently, mortality rates for all ages are very near zero as deaths per day are so low.
Cases increasing in the young and decreasing among the elderly is how the number of deaths can continue to fall even if cases found by the ONS surveillance study remain the same or even rise slightly, as long as fewer older people have the disease as compared to more younger people over time.
There is growing concern of younger people passing the disease to older people, but if a young person has had the disease, and is then very unlikely to have it in future, their chance of passing it on to an older person in future is much diminished. This is another reason for not hitting the panic button when case numbers rise.
Reaching a true mortality rate
Eventually, mortality rates from COVID-19 will fall as the proportion of people who have had it rises. The final graph below tries to illustrate just how far away from that point we are, but how we have clearly been moving towards it over the course of the past two months.
The graph shows the ratio of deaths to every 1,000 cases recorded each day. This is a crude measure, as mortality lags behind positive cases, but it is still a useful guide.
We can see that the number of people dying of COVID-19 falls from 217 for every 1,000 testing positive across all of England and Wales on June 24 (when so few people were being tested), to four by the end of August and just two per 1,000 by September 4. The fall is so fast and so great that a log scale is required to encompass it in one graph.
The fall cannot continue at this rate for much longer, and where the ratio eventually settles will be below the theoretical upper limit for the actual final overall mortality rate from this disease; a rate which we do not yet know.
The above is from the UK. From my own perspective in Austria, I see similar, the numbers tell the story on the site of the Austrian Ministry of Health.